Arvee Laboratories (India) (Arvee) started its operations with an aim to become a leader & frontrunner in chemical industry by providing the best and innovative quality chemical products. The company intended to establish eco-friendly organization dedicated to providing good quality innovative products at very competitive price. Keeping quality and precision as the benchmark for any operation, Arvee hails to become the most sought-after chemical manufacturing company offering best products at very reasonable price. Quality, Service and Advancement are the mainstay of the company which has brought it this far in the chemical industry. From humble beginnings, Arvee has carved a remarkable presence in the chemical industry in a very short span.

Ever since inception, quality has been a constant and guiding factor in every practice at Arvee. More than a practice it is a pledge taken by each and every member of its team to stay committed and true to the highest quality standards. This enables the company to manufacture best quality products while taking care of safekeeping the environment and personnel. Over the years, its commitment to maintaining high quality standards in an eco-friendly way has helped it to build long-lasting and rewarding relationships with its clients. As part of the quality policy, every process and practice at Arvee is committed to greater cause of keeping the environment safe and sustainable.

The company was incorporated as ‘Arvee Laboratories (India) Private Limited’ under the provisions of the Companies Act, 1956 vide certificate of incorporation dated January 27, 2012 in Ahmedabad, Gujarat. Subsequently, the name of the company was changed to ‘Arvee Laboratories (India) Limited’ pursuant to shareholder’s resolution on September 11, 2017 and vide fresh certificate of incorporation dated September 19, 2017.

Business area of the company

Arvee is engaged in manufacturing of specialized chemicals. The plant facilities and other utility services at Arvee are equipped to undertake a host of processes namely, Nitration, Sulfonation, Reduction, Halogenation, Esterification, Alkylation, Acylation, Hoffman Reaction, Grignard Reaction, Vilsmeyer Heack Reaction, Sandmeyer Reaction, Caustic Fusion, Friedel-Crafts Reaction and Catalytic Reduction. The company caters to the demand of both domestic as well as international markets.

Products

Polymer Modifiers

• Dimethyl 5-Sodiosulfoisophthalate
• 5-Sulfoisophthalic Acid Mono Sodium Salt
• 5-Sulfoisophthalic Acid Mono Lithium Salt
• 5-Sodiosulfo-Bis-(β-Hydroxyethyl)-Isophthalate

Contrast Media Intermediates

• 5-Nitroisophthalic acid
• Dimethyl 5-Nitroisophthalate
• Monomethyl 5-Nitroisophthalate
• 5-Hydroxyisophthalic acid
• 5-Aminoisophthalic acid
• Dimethyl 5-Aminoisophthalate
• 3,5-Dinitrobenzoic Acid
• 3,5-Diamino Benzoic Acid

Drug Intermediates

• 2-Acetyl Thiophene
• Thiophene-2-Carboxaldehyde
• 4-Amino Pyridine
• 2-Chloro-5-nitrobenzoic acid

Major Events and Milestones:

• 2012: The company was incorporated as Arvee Laboratories (India) Private Limited.
• 2013: Acquired land, building and machineries from Skylink Chemicals Private Limited and started manufacturing unit.
• 2013: Started construction of its first plant for Thiophene Derivatives.
• 2013: Completes construction and commissioning of its Thiophene Derivatives Plant.
• 2014: Plant inspected and approved by leading India pharmaceutical manufacturer for supply of Thiophene Derivatives.
• 2014: Started construction of plant for Sulfo and Nitro Derivatives of Isophthalic Acid.
• 2014: Received ISO 9001:2008 accreditation for NABCB and DAKKS from TUV NORD.
• 2014: Plant inspected and approved by an American X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer.
• 2014: Plant inspected and approved by a European X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer.
• 2015: Completed construction and commissioning of plant for Nitro Derivatives of Isophthalic Acid.
• 2015: After receiving inspection approval, the Company gets order for yearly supply of Nitro Derivatives of Isophthalic Acid to leading contrast media manufacturer in the United States of America.
• 2015: Export to United States of America (USA) started.
• 2015: Plant inspected and approved by European manufacturer for supply of Thiophene Derivatives. 
• 2015: Export of Thiophene Derivatives started to Europe.
• 2016: Receives internal approvals for their Nitro Derivatives of Isophthalic acid from leading X- Ray contrast media manufacturer in Europe.
• 2016: Receive approval for the Sulfo Derivatives of Isophthalic acid from a large polymer manufacturer in the United States of America and received yearly order for supply of Sulfo Derivatives to the USA.
• 2016: Crossed turnover of Rs 25 crores.
• 2017: Plant inspected and approved by an American X-ray contrast media manufacturer who has the largest market share in the world and started of pilot trials with the manufacturer.
• 2017: Received order for commercial trials of Nitro Derivatives of Isophthalic acid from the largest manufacturer of X-ray contrast media manufacturer in the world.
• 2017: The name of the company was changed to Arvee Laboratories (India) Limited pursuant to conversion into a public limited company.
• 2021: Sold its 100% investment in its subsidiary company namely ‘Arvee Speciality Chemicals’ and ceased to be subsidiary of company.